Skip to main content

Published locations for FDA approves pembrolizumab for relapsed/refractory PMBCL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves pembrolizumab for relapsed/refractory PMBCL

User login

  • Reset your password
  • /content/fda-approves-pembrolizumab-relapsed/refractory-pmbcl
  • /hematologynews/article/168134/aggressive-lymphomas/fda-approves-pembrolizumab-relapsed/refractory
  • /oncologypractice/article/168134/aggressive-lymphomas/fda-approves-pembrolizumab-relapsed/refractory
  • /hematologynews/nhlhub/article/168134/aggressive-lymphomas/fda-approves-pembrolizumab-relapsed
  • /hematology-oncology/article/168134/aggressive-lymphomas/fda-approves-pembrolizumab-relapsed